A phase 3 trial evaluating Moderna’s investigational seasonal influenza vaccine, mRNA-1010, found the messenger RNA ...
LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...
Guselkumab (Tremfya) showed higher 24-week fistula remission than placebo in adults with perianal fistulizing Crohn disease.
On the heels of FDA’s clearance, the company plans to begin a Phase Ib/IIa trial evaluating CK0802 in patients who have ...
Lastly, a broader view of clinical outcomes and operational insights is a cornerstone to product value translation. Gathering ...
Execution instability often originates in strategy timing rather than study conduct, which sponsors can correct by ...
In a recent video interview with Applied Clinical Trials, Hal Green, senior solution architect and life sciences vertical ...
As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...
In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, offers a ...
In this video interview, Hal Green, senior solution architect and life sciences vertical lead EMEA at Loftware, discusses why ...
In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, identifies ...
In today’s ACT Brief, we highlight where AI is delivering real gains in protocol development, how geopolitical disruption is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results